AVRA Medical Robotics, Inc.
AVMR
Other OTC9.17
USD
- -
- -
CIK
0001676163
Return %
Stock
S&P500
1Y
31,520.69
26.53
3Y
274.29
76.60
5Y
-38.87
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Barry F. Cohen
- Full Time Employees
- 2
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 3259 Progress Drive Orlando FL United States of America 32826
- CIK
- 0001676163
- Website
- avramedicalrobotics.com
- Similar Companies
- Business
- AVRA Medical Robotics, Inc. is a medical technology company specializing in the development of fully autonomous surgical robotic systems designed to automate a wide range of medical procedures traditionally performed by human hands. Its core products include its proprietary SSI Mantra surgical robotic system and associated surgical instruments, with an emphasis on treatment-independent precision guidance systems applicable to minimally and non-invasive procedures such as biopsies, tissue targeting, neurological repair, and internal organ interventions. AVRA integrates advanced surgical robotics with artificial intelligence, proprietary medical software architecture, and oVio Technologies' 360-degree dimensional imaging technology to enhance navigation accuracy and procedural safety. The company targets global medical markets with planned regulatory approvals in the United States, Canada, Europe, Australia, Japan, and Brazil. Founded in 2015 and headquartered in Newport Beach, California, AVRA operates primarily in the medical robotics industry and collaborates with technology partners to expand its autonomous robotic applications. In the latest significant developments, AVRA completed a merger with SS Innovations International, Inc. in April 2023 and subsequently began trading on the U.S. OTC Market under the ticker symbol AVMR. This merger extended AVRA's product portfolio and market reach. Additionally, the company has recently appointed key medical and scientific advisors to accelerate development efforts. AVRA has also made strategic partnerships, notably with oVio Technologies, to utilize advanced imaging technology aimed at creating a fully autonomous surgical robot capable of precise navigation and targeting. The company has conducted and completed a human factors validation study for the SSI Mantra system, representing a major step toward commercialization and regulatory approvals. AVRA is actively progressing toward FDA approval for its fully autonomous surgical systems and expanding its operational footprint with ambitions for global market penetration. AVRA Medical Robotics emphasizes innovation in robotic surgery with a comprehensive suite of robotic systems and software designed for various medical disciplines, including aesthetic, neurological, and internal organ procedures, addressing the growing need for robotic automation amid a declining specialist workforce. Its development approach focuses on precision, safety, speed, and treatment independence through advanced software paired with proven surgical instrumentation, positioning AVRA as a forefront contender in next-generation medical robotics. The company's ongoing research and commercial strategies reflect a commitment to transforming surgical practices worldwide through robotic automation and AI-driven solutions.
AVRA Medical Robotics, Inc. Appoints Dr. Onur Toker to Accelerate Development of its Surgical Robotic System
AVRA Medical Robotics, Inc. Appoints Dr. Onur Toker to Accelerate Development of its Surgical Robotic System
AVRA Medical Robotics' Chief Medical Officer to Reveal Company's Latest Developments in Surgical Robots at Global Conference